Topol to Scripps
Executive Summary
Former Cleveland Clinical Department of Cardiovascular Medicine Chair Eric Topol will lead new Scripps Translational Science Institute. Topol will serve as chief academic officer and chief of genomic medicine and translational sciences, as well as a senior consultant in the San Diego-based healthcare system's cardiology division. Topol left the Cleveland Clinic in February after 15 years heading its cardio program (1"The Pink Sheet" Feb. 13, 2006, In Brief)...
You may also be interested in...
Topol departs Cleveland Clinic
Eric Topol, an outspoken critic of COX-2 inhibitors and a witness in Vioxx product liability cases, resigns from his position as chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic. Topol will join the Department of Genetics at Case Western University. He will continue to work with the Cleveland Clinic as a consultant and serve as program director of an NIH grant in collaboration with the clinic. A study of Pfizer's COX-2 Celebrex will be conducted at the Cleveland Clinic under the direction of Steven Nissen (1"The Pink Sheet" Dec. 19, 2005, p. 18)...
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.